Neoplasia/BPH

	Evaluation of the relationship between pan-immune inflammation value and prognostic factors in germ-cell testicular cancer: analysis of stage, lymph node involvement, and metastasis. Turk J Med Sci Dinçer E, Özkaptan O, Çanakçi C, Ipek OM, Co, Sevinç AH. PMID: 41816726 [PubMed - indexed for MEDLINE]
	Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario? Front Immunol Cerbone L, Roviello G, Calabrò F, Taha T, Grande E, Binz K, Kanesvaran R, Pirstuk A, Fiala O, Molina-Cerrillo J, Alonso-Gordoa T, Rizzo A, Pichler R, Myint ZW, Poprach A, Facchini G, Bohuslav M, Studentova H, Morelli F, Buchler T, Mennitto A, Tural D, Formisano L, Orejana I, Catalano M, Buti S, Monteiro FSM, Soares A, Gupta S, Massari F, Santoni M. PMID: 41816343 [PubMed - indexed for MEDLINE]
	bp-VI-RADS combined with normalized apparent diffusion coefficient enhances diagnostic efficacy for muscle-invasive bladder cancer. Quant Imaging Med Surg Hao Z, Zhu L, Ding J, Jin Q, Du X, Wang X, Shi Y, Guo H, Li D, Yang R. PMID: 41816041 [PubMed]
	Diagnosis of bladder diverticular tumor by transrectal biplanar ultrasonography: a case report. Int J Surg Case Rep You Y, Li L, Liu X, Xing J, Fan X. PMID: 41815992 [PubMed]
	Defining the learning curve for thulium Laser en bloc resection of bladder tumors: a single-surgeon retrospective cohort study. Front Surg Qing X, Wu X, Gao W. PMID: 41815783 [PubMed]
	Risk of second primary malignancies in prostate cancer patients: A Surveillance, Epidemiology, and End Results population-based study. Asian J Urol Shou J, Wo Q. PMID: 41815370 [PubMed]
	Recurrence and prevention strategies for non-muscle-invasive bladder cancer: A comprehensive review. Asian J Urol Liu W, Xiao J, Zou J, He Z. PMID: 41815366 [PubMed]
	Neoadjuvant androgen deprivation therapy with bicalutamide compared to hormonal agents in treating high-risk prostate cancer: a real-world cohort study. Transl Cancer Res Liu J, Cui Y, Tang X, Ma J, Du P. PMID: 41815147 [PubMed]
	Allergy to cabazitaxel: Cross-reactivity between taxanes. Allergol Immunopathol (Madr) Fernández-Paredes PC, Guerrero MN, de la Puente EP, Lopez-Sanchez JD. PMID: 41814617 [PubMed - indexed for MEDLINE]
	Vitamin D and Bladder Cancer Risk: An Umbrella Review and Second Order Meta-Analysis. Cancer Med Mancin S, Ferrara G, Palomares SM, Matteucci S, Santagostino AM, Ferrari G, Parozzi M, Petrelli F, Hurle R, Sguanci M, Cangelosi G. PMID: 41814462 [PubMed - indexed for MEDLINE]
	Ultrasound-assisted diagnosis and ultrasound-guided radiofrequency ablation of renal cell carcinoma in a patient with autosomal dominant polycystic kidney disease: a case report with two-year follow-up. BMC Nephrol Yu X, Liu R, Sun Z, Wang L, Ma J, Wang S, Liu X, Zhang B. PMID: 41814207 [PubMed - as supplied by publisher]
	Management of Lower Urinary Tract Symptoms in Patients on Active Surveillance for Prostate Cancer. Curr Urol Rep Kapoor J, Cheung F. PMID: 41813844 [PubMed - in process]
	Pilot study of dual-arm absolute quantification of miR-130a and miR-365a in plasma and urine reveals 3p/5p strand-ratio shifts in prostate cancer. Sci Rep Romanescu M, Bendelic AI, Ciordas PD, Dema V, Bardan TR, Cumpanas AA, Chis AR, Marian C, Sirbu LO. PMID: 41813789 [PubMed - as supplied by publisher]
	Incomplete thermal ablation accelerates local and systemic tumor progression in an immunocompetent prostate cancer model. Int J Hyperthermia Kader A, Ranner-Hafferl MHH, Polz AL, Mülleder M, Farztdinov V, Fendler A, Collettini F, Auer TA. PMID: 41813588 [PubMed - indexed for MEDLINE]
	Targeted and Perilesional or Systematic Biopsies in Prostate Cancer: The TARGET Clinical Trial Protocol. Eur Urol Oncol Baboudjian M, Sordelli F, Patard JJ, Moussi B, Graffeille V, Basset V, Legraverend D, Bastide C, Daniel L, Beauval JB, Rouprêt M, Robert G, Ploussard G. PMID: 41813528 [PubMed - as supplied by publisher]
	From bench to bedside: translating the histone deacetylase inhibitors into prostate cancer therapies. Clin Chim Acta Rocha SM, Brás MB, Pereira BJ, Maia CJ. PMID: 41812786 [PubMed - as supplied by publisher]
	Reirradiation Options for Previously Irradiated Prostate Cancer: Is It Feasible to Randomise Between Treatment With Stereotactic Body Radiotherapy (SBRT) Versus High-Dose-Rate Brachytherapy? Clin Oncol (R Coll Radiol) Zhong J, Slevin F, Brown S, Serra M, Bownes P, Thompson C, Reed R, Reeves K, Dubec M, Eccles C, Chuter R, Tsang YM, Taylor NJ, West CML, Buckley D, Alonzi R, Scarsbrook A, Choudhury A, Hoskin P, Henry AM. PMID: 41812301 [PubMed - as supplied by publisher]
	European Study of Prostate Cancer Screening - 23-Year Follow-up. N Engl J Med PMID: 41812212 [PubMed - in process]
	Association of Family History and Polygenic Risk Scores With Prostate Cancer in Africa. JCO Glob Oncol Odole I, Andrews C, Agalliu I, Rohan T, Fernandez PW, Irusen H, Ntlaba SJ, Janivara R, Lachance J, Baichoo S, Mensah JE, Adjei AA, Abrahams AOD, Quarchie MN, Aisuodionoe-Shadrach OI, Nwegbu MM, Jamda MA, Oluwole PO, Chen WC, Joffe M, Adusei B, Doherty S, Pentz A, Adebiyi A, Ogunbiyi O, Jalloh M, Rebbeck TR. PMID: 41812093 [PubMed - indexed for MEDLINE]
	Bridging the Gap: The Role of Shared Decision-Making in Addressing Racial and Ethnic Disparities in Prostate-Specific Antigen Screening. Oncol Nurs Forum Joung HH, Martin DN, Jones RA. PMID: 41812019 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 186269

Page 1 of 9314



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy